What does CUSIP 00430K402 represent in this 13F holders report?

CUSIP 00430K402 is the security identifier for ACST - ACASTI PHARMA INC - CL A NEW used to aggregate holder disclosures.

How many institutions held ACST - ACASTI PHARMA INC - CL A NEW in Q1 2019?

13 institutional investors reported ACST - ACASTI PHARMA INC - CL A NEW for Q1 2019. Use the holders table for investor-level position and value details.

ACASTI PHARMA INC - CL A NEW (ACST)

CUSIP: 00430K402

Q1 2019 13F Holders as of 31 Mar 2019

Security type / class: Equity / CL A NEW
Total 13F shares: 2,506,733
Total 13F value: $2,553,950
Share change: -243,575
SEC-reported price per share: $1.02
Number of holders: 13
Value change: -$172,211
Number of buys: 8
Number of sells: 4

Security key

00430K402

Report period

Q1 2019

Institutions

Top holders

ACST full security history Ownership snapshot Full 13F holder table Grace Therapeutics, Inc. SEC filings Grace Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ACST - ACASTI PHARMA INC - CL A NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

PERCEPTIVE ADVISORS LLC

Disclosed value leader

PERCEPTIVE ADVISORS LLC

Comparable rows

0/12

Latest evidence

31 Dec 2018

13F Highest disclosed value: $1,480,000 12 rows are not safely comparable across share classes. Showing 1-6 of 12 holder rows.

Quick read

PERCEPTIVE ADVISORS LLC has the largest disclosed position value at $1.48M.

0 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.

Disclosed position value Top 5

PERCEPTIVE ADVISORS LLC $1.48M

SABBY MANAGEMENT, LLC $229K

BANK OF MONTREAL /CAN/ $206K

PURA VIDA INVESTMENTS, LLC $157K

CITADEL ADVISORS LLC $50K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 12 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
PERCEPTIVE ADVISORS LLC	13F Company 13F	— denominator unverified	$1,480,000 1,779,882 shares	—	31 Dec 2018
SABBY MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$229,000 275,000 shares	—	31 Dec 2018
BANK OF MONTREAL /CAN/	13F Company 13F	— denominator unverified	$206,000 247,412 shares	—	31 Dec 2018
PURA VIDA INVESTMENTS, LLC	13F Company 13F	— denominator unverified	$157,000 188,260 shares	—	31 Dec 2018
CITADEL ADVISORS LLC	13F Company 13F	— denominator unverified	$50,000 60,218 shares	—	31 Dec 2018
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$40,000 48,665 shares	—	31 Dec 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

2,506,733

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q1 2019 Shares	Share Diff	Share Chg %	Q1 2019 value	Q1 2019 value	Value change	Value Chg %